CVKD · Cadrenal Therapeutics, Inc. · Exempt Offerings
$0.94
0.00 (-0.47%)
At close · Oct 29
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$3.38M
Shares
3.57M
Volume · Oct 29
44.03K
Avg daily vol (3M)
461.96K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-07-15 | New | Biotechnology | $8,843,849 | $8,843,849 | 06b |
| 2026-04-06 | New | Biotechnology | $7,923,235 | $7,923,235 | 06b |
| 2025-12-31 | New | Biotechnology | $4,396,329 | $4,396,329 | 06b |
| 2024-11-14 | New | Biotechnology | $9,428,594 | $9,428,594 | 06b |
| 2023-07-18 | New | Biotechnology | $7,500,001 | $7,500,001 | 06b |
| 2022-12-08 | New | Biotechnology | $1,000,000 | $250,000 | 06b |
| 2022-07-25 | New | Biotechnology | $2,000,000 | $150,000 | 06b |
Showing 1–7 of 7 filings